Showing results (691-700 of 4,871) with videos related to
Sort By:
Pageof 488
Urologic Oncology|March 8, 2006
Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary resultsEssam Elsamman, Tomoharu Fukumori, Ashraf A Ewis, et al.Urologic Oncology|March 8, 2006
Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer modelBenjamin K Canales, Yingming Li, Melissa G Thompson, et al.Urologic Oncology|March 8, 2006
The application of epigenetic modifiers on the treatment of prostate and bladder cancerZhengwang Zhang, Jose Karam, Eugene Frenkel, et al.Urologic Oncology|March 8, 2006
Development of the VCaP androgen-independent model of prostate cancerRobert D Loberg, Lauren N St John, LaShon L Day, et al.Urologic Oncology|May 9, 2006
Single nucleotide polymorphisms: early diagnosis and risk assessment in genitourinary malignancyAdam S KibelUrologic Oncology|May 9, 2006
Cancer immunomics: using autoantibody signatures in the early detection of prostate cancerTimothy J Bradford, Xiaoju Wang, Arul M ChinnaiyanUrologic Oncology|October 2, 2010
Current second-line treatment options for patients with castration resistant prostate cancer (CRPC) resistant to docetaxelChristian Arsov, Christian Winter, Robert Rabenalt, et al.Urologic Oncology|October 2, 2010
Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adultsSean R Williamson, Antonio Lopez-Beltran, Gregory T MacLennan, et al.Urologic Oncology|July 9, 2010
Statistical consideration for clinical biomarker research in bladder cancerShahrokh F Shariat, Yair Lotan, Andrew Vickers, et al.Urologic Oncology|July 9, 2010
Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progressionDavid J McConkey, Sangkyou Lee, Woonyoung Choi, et al.Pageof 488